Correlation between prostate-specific antigen and bone scan findings in patients with prostate cancer at Grey’s Hospital, KwaZulu-Natal: A retrospective chart review

Many studies have indicated that prostate-specific antigen (PSA) is used for the detection and monitoring of prostate cancer. We analysed PSA levels and bone scan findings to determine whether PSA can accurately predict bone metastases. A study was conducted at Grey’s Hospital, a public hospital in Pietermaritzburg, KwaZulu-Natal, South Africa. A total of 84 patients were included in this study: 61 (72.62%) black patients, 14 (16.67%) Indian and 9 (10.71%) white patients. Our study indicated a high correlation between PSA level and bone scan finding. We arrived at a conclusion that at PSA level > 24 ng/mL, bone scan is highly recommended.